File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study

TitlePredictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study
Authors
Issue Date2021
Citation
Acta Diabetologica, 2021, v. 58, n. 2, p. 171-180 How to Cite?
AbstractIntroduction: Emerging evidence suggests that HbA1c variability, in addition to HbA1c itself, can be used as a predictor for mortality. The present study aims to examine the predictive power of mean HbA1c and HbA1c variability measures for diabetic complications as well as mortality. Methods: The retrospective observational study analyzed diabetic patients who were prescribed insulin at outpatient clinics of the Prince of Wales Hospital and Shatin Hospital, Hong Kong, from 1 January to 31 December, 2009. Standard deviation (SD), root mean square (RMS), and coefficient of variation were used as measures of HbA1c variability. The primary outcomes were all-cause and cardiovascular mortality. Secondary outcomes were diabetes-related complications. Results: The study cohort consists of 3424 patients, including 3137 patients with at least three HbA1c measurements. The low mean HbA1c subgroup had significantly shorter time-to-death for all-cause mortality (P < 0.001) but not cardiovascular mortality (P = 0.920). The high Hba1c subgroup showed shorter time-to-death for all-cause (P < 0.001) and cardiovascular mortality (P < 0.001). Mean Hba1c and Hba1c variability predicted all-cause as well as cardiovascular-specific mortality. In terms of secondary outcomes, mean HbA1c and HbA1c variability significantly predicted diabetic ketoacidosis/hyperosmolar hyperglycemic state/diabetic coma, neurological, ophthalmological, and renal complications. A significant association between dichotomized HbA1c variability and hypoglycemia frequency was found (P < 0.0001). Conclusion: High HbA1c variability is associated with increased risk of all-cause and cardiovascular mortality, as well as diabetic complications. The association between hypoglycemic frequency, HbA1c variability, and mortality suggests that intermittent hypoglycemia resulting in poorer outcomes in diabetic patients.
Persistent Identifierhttp://hdl.handle.net/10722/330659
ISSN
2023 Impact Factor: 3.1
2023 SCImago Journal Rankings: 0.980
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLee, Sharen-
dc.contributor.authorLiu, Tong-
dc.contributor.authorZhou, Jiandong-
dc.contributor.authorZhang, Qingpeng-
dc.contributor.authorWong, Wing Tak-
dc.contributor.authorTse, Gary-
dc.date.accessioned2023-09-05T12:12:52Z-
dc.date.available2023-09-05T12:12:52Z-
dc.date.issued2021-
dc.identifier.citationActa Diabetologica, 2021, v. 58, n. 2, p. 171-180-
dc.identifier.issn0940-5429-
dc.identifier.urihttp://hdl.handle.net/10722/330659-
dc.description.abstractIntroduction: Emerging evidence suggests that HbA1c variability, in addition to HbA1c itself, can be used as a predictor for mortality. The present study aims to examine the predictive power of mean HbA1c and HbA1c variability measures for diabetic complications as well as mortality. Methods: The retrospective observational study analyzed diabetic patients who were prescribed insulin at outpatient clinics of the Prince of Wales Hospital and Shatin Hospital, Hong Kong, from 1 January to 31 December, 2009. Standard deviation (SD), root mean square (RMS), and coefficient of variation were used as measures of HbA1c variability. The primary outcomes were all-cause and cardiovascular mortality. Secondary outcomes were diabetes-related complications. Results: The study cohort consists of 3424 patients, including 3137 patients with at least three HbA1c measurements. The low mean HbA1c subgroup had significantly shorter time-to-death for all-cause mortality (P < 0.001) but not cardiovascular mortality (P = 0.920). The high Hba1c subgroup showed shorter time-to-death for all-cause (P < 0.001) and cardiovascular mortality (P < 0.001). Mean Hba1c and Hba1c variability predicted all-cause as well as cardiovascular-specific mortality. In terms of secondary outcomes, mean HbA1c and HbA1c variability significantly predicted diabetic ketoacidosis/hyperosmolar hyperglycemic state/diabetic coma, neurological, ophthalmological, and renal complications. A significant association between dichotomized HbA1c variability and hypoglycemia frequency was found (P < 0.0001). Conclusion: High HbA1c variability is associated with increased risk of all-cause and cardiovascular mortality, as well as diabetic complications. The association between hypoglycemic frequency, HbA1c variability, and mortality suggests that intermittent hypoglycemia resulting in poorer outcomes in diabetic patients.-
dc.languageeng-
dc.relation.ispartofActa Diabetologica-
dc.titlePredictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s00592-020-01605-6-
dc.identifier.pmid32939583-
dc.identifier.scopuseid_2-s2.0-85090942793-
dc.identifier.volume58-
dc.identifier.issue2-
dc.identifier.spage171-
dc.identifier.epage180-
dc.identifier.eissn1432-5233-
dc.identifier.isiWOS:000570024200001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats